In a bold move that’s sure to spark debate, the Texas Rangers have secured a 2-year, $14.5 million deal with free agent catcher Danny Jansen, raising questions about his injury history and future impact. But here's where it gets controversial: is Jansen’s offensive potential worth the gamble, given his frequent injuries and inconsistent playing time? Let’s dive in.
The Rangers, seeking a reliable partner for Kyle Higashioka behind the plate, finalized the agreement on Friday, according to sources close to the negotiations. At 30, Jansen has shown flashes of brilliance as one of baseball’s better-hitting catchers, but his career has been marred by injuries that have limited his on-field presence. Despite this, his 10.8 fWAR since 2018 ranks him 10th among MLB catchers, though his performance has been a rollercoaster. Last season, he split time between the Tampa Bay Rays and Milwaukee Brewers, catching 93 games and posting a slightly above-average 103 wRC+.
And this is the part most people miss: Jansen’s value isn’t just in his bat—it’s also in his ability to provide stability at a position where offense is often hard to come by. While defensive metrics label him as capable but not exceptional, his blocking skills outshine his framing abilities. This unique blend of skills has kept him in demand, even with a career-high of only 100 games played in a single season.
Jansen’s journey has been anything but ordinary. Drafted out of high school by the Toronto Blue Jays in 2013, he made his MLB debut in 2018 and eventually replaced Russell Martin as the team’s primary catcher. From 2021 to 2023, he boasted a 121 wRC+, the eighth-best among catchers during that period. However, injuries to his hamstring, oblique, hand, and groin restricted him to fewer than 301 plate appearances annually. In 2024, a broken wrist further sidelined him, though he made MLB history as the first player to appear for both teams in the same game after a rain-delayed match between the Blue Jays and Red Sox following his trade to Boston.
Last offseason, the Rays signed Jansen to a one-year, $8.5 million deal, prioritizing his defensive stability. Despite trading him to the Brewers at the deadline, he posted a solid .779 OPS down the stretch. Yet, Milwaukee surprisingly left him on the bench during the postseason and declined his $12 million mutual option for 2026.
Here’s the million-dollar question: Can Jansen stay healthy and regain his peak form with the Rangers? Or will his injury-prone nature continue to overshadow his offensive promise? The Rangers are clearly betting on the former, but only time will tell.
Meanwhile, the Rangers have been busy on other fronts, agreeing to one-year deals with relievers Alexis Diaz and Tyler Alexander. As for Higashioka, 35, he’s entering the final guaranteed year of his contract, with a $7 million mutual option for 2027 that’s unlikely to be exercised by either party.
What do you think? Is Jansen’s signing a stroke of genius or a risky gamble? Let us know in the comments—we’re eager to hear your take!
